Briefing: Eli Lilly opposes push to pass Trump's drug pricing deals into law, CEO says

Eli Lilly's CEO Dave Ricks spoke with CNBC.

The company opposes the 'most favored nation' drug pricing proposal.

The push is part of a broader effort by the White House.